Masitinib

Masitinib is a member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N3-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. Among its listed roles, it functions as a antineoplastic agent, an antirheumatic drug, a tyrosine kinase inhibitor and anti-inflammatory agent at the cellular level. It belongs to the class of benzamides, a member of pyridines, a member of 1,3-thiazoles and a N-alkylpiperazine. It is grouped under the following drug class(es): Tyrosine Kinase Inhibitors. Its therapeutic use is listed as anti-inflammatories. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Masatinib. Its PubChem CID is 10074640.

CAS No 790299-79-5
Molecular Formula C28H30N6OS
Molecular Weight 498.6 g/mol
Synonyms 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide

Frequently Asked Questions